5:30 - 6:00 pm

6:00 - 8:00 pm

Networking Dinner and Guest Speakers

Bio Address
John Crowley, President/CEO, Biotechnology Innovation Organization (invited) 

Presentation of the AURP Vision Award
Pete Pellerito, Biotechnology Innovation Organization 

Welcome
Ben Bradford, Head of External Affairs, Mass Bio

Fireside Chat
The Boom in Bio and Pharma Manufacturing: What States Need to Know
Billions of dollars in new bio and pharma manufacturing hubs are being announced weekly as corporations respond to reshoring manufacturing spurred by tariffs, presidential executive orders and global supply chain realignment. Learn how regions are planning and incentivizing bio and pharma manufacturing in their states in this interactive panel. 

Speakers:
Monique K Mansoura, PhD, MBA, Global Health Security & Biotechnology, Strategic Advisor
Eddie Pauline, President and CEO, Ohio Life Sciences

7:30 - 8:00 am

Check-In & Networking | Continental Breakfast Served

8:00 - 8:15 am

Welcoming Remarks

Speaker:
Vinit Nijhawan, Managing Director, MassVentures

8:15 - 8:45 am

Headwinds in Protecting Bio Innovations
Explore challenges in IP protection, the role of the Bayh-Dole Act in fostering innovation, and policy aimed at enhancing the competitiveness of regions in the biotechnology sector. Steve Susalka will address strategies to strengthen IP frameworks and support regional innovation ecosystems. 

Speaker:
Steve Susalka, CEO, AUTM

8:45 - 9:30 am

Life Science Labs of the Future
Focus on the evolving design and infrastructure of life science laboratories. These experts will discuss innovative approaches to lab development, sustainability, and collaboration, plus features experiences and insights from IU Labs.

Speakers: 
Kurt Fullbeck, Director of IU LAB Initiatives and Partnerships, Indiana University
Tzveta Panayotova, Principal, HDR
Aaron Kazam, Executive Vice President, Acquisitions & Development, Breakthrough Properties

9:30 - 10:00 am

Bio Manufacturing in Space: The Future of New Drugs and Devices
The “skies the limit” with the potential of space-based bio-manufacturing to revolutionize the development of new drugs and devices. Representatives from Tech Connect, MassChallenge, and CASIS International Space Station will highlight advancements and opportunities in accessing space for cutting-edge biomanufacturing. 

Speakers:
Donna Roberts, Deputy Chief Scientist, CASIS International Space Station National Lab
Representatives invited from Tech Connect and MassChallenge

10:00 - 10:30 am

10:30 - 11:00 am

Bio Hubs Across the Country: What's Hot and What's Not?
Learn emerging trends in life sciences hubs across the U.S., highlighting the regions that are thriving and those facing challenges. Our informed and entertaining authorities will provide insights into the factors driving success and the evolving landscape of life sciences innovation. 

Speakers:
Alex Philippidis, Senior Business Editor, GEN News
Matt Gardner, Head of Life Sciences, Americas, CBRE (invited)
Rachel Rath, MBA, MPH, Head, JLabs @ Washington, D.C.

11:00 - 11:30 am

Navigating the New Normal and Life Science Workforce
Recruiting a robust life science workforce always been difficult, but emerging bio funding uncertainties, international tensions and rapidly changing technologies present new challenges.  Will familiarity with AI and quantum tech overtake the need for fundamental biology research experience? Will labs on a chip eliminate the need for workforce used to working with vivaria and animal models? Hear from experts on how regions should prepare for the life science workforce of the future.

Speakers:
Brian Gaines, Chief Executive Officer, Learning Undefeated
Randall Ribaudo, Co-Founder, Human Workflows and SciPhD
Amrita Madabushi, Collegiate Professor of Biotechnology, University of Maryland Global Campus; CEO, EmpowerBio
Representatives invited from AstraZeneca, Invest Ontario, Women in BIO and other US-based organizations  

11:30 - 11:55 am

Bio R&D and Manufacturing Headwinds in an Uncertain Macro Environment
Funding for life sciences is facing massive challenges, from the slashed federal funds in Trump’s latest budget proposal to the tariffs that threaten the influx of cash from biopharma investors. How will drug development evolve?

Speakers:
Jef Akst, Managing Editor, BioSpace
Lori Ellis, Head of Insights, BioSpace
Heather McKenzie, Senior Editor, BioSpace

11:55 am - 12:00 pm